diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

FDA Drug Profile — QUADRACEL

Drug Details

Generic Name
diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Brand Names
QUADRACEL
Application Number
BLA125525
Sponsor
Sanofi Pasteur Inc.
NDC Codes
1
Dosage Forms
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)